Cecha
Depression
Frequently experiencing feelings of being down, miserable, and/or hopeless; struggling to recover from these moods; having a pessimistic outlook on the future; feeling a pervasive sense of shame; having a low self-worth; experiencing thoughts of suicide and engaging in suicidal behavior.
Podsumowanie
- Znana także jako
- Depressive episode, Depressivity
- Układ organizmu
- Abnormality of the nervous system
Genom referencyjnyGRCh38hg38
Pozycje na stronach genów i wariantów zależą od tego wyboru, w tej przeglądarce.
Read the genes linked to Depression, and the rest of your genome, with one test.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni
Zamawiam Genome Test464 genów powiązanych z Depression
Zmiany w tych genach powodują rzadkie choroby, w których występuje Depression. Większość osób z tą cechą nie ma żadnej z tych chorób, a gen z tej listy nic nie mówi o czyimkolwiek własnym genomie.
| Gen | Jak często występuje | Choroby |
|---|---|---|
| ABCB7ATP binding cassette subfamily B member 7 | Zawsze | W 2 chorobach |
| AMACRalpha-methylacyl-CoA racemase | Zawsze | W 2 chorobach |
| ARHGEF15Rho guanine nucleotide exchange factor 15 | Zawsze | W 1 chorobie |
| COX18cytochrome c oxidase assembly factor COX18 | Zawsze | W 1 chorobie |
| CST3cystatin C | Zawsze | W 1 chorobie |
| CTSAcathepsin A | Zawsze | W 1 chorobie |
| DNAJC5DnaJ heat shock protein family (Hsp40) member C5 | Zawsze | W 1 chorobie |
| FDXRferredoxin reductase | Zawsze | W 1 chorobie |
| FRYLFRY like transcription coactivator | Zawsze | W 1 chorobie |
| ITPR1inositol 1,4,5-trisphosphate receptor type 1 | Zawsze | W 1 chorobie |
| LAMB1laminin subunit beta 1 | Zawsze | W 1 chorobie |
| LRRC7leucine rich repeat containing 7 | Zawsze | W 1 chorobie |
| MAU2MAU2 sister chromatid cohesion factor | Zawsze | W 1 chorobie |
| MPV17mitochondrial inner membrane protein MPV17 | Zawsze | W 1 chorobie |
| PER3period circadian regulator 3 | Zawsze | W 1 chorobie |
| PLP1proteolipid protein 1 | Zawsze | W 1 chorobie |
| POLG2DNA polymerase gamma 2, accessory subunit | Zawsze | W 2 chorobach |
| RAB3ARAB3A, member RAS oncogene family | Zawsze | W 1 chorobie |
| SGCEsarcoglycan epsilon | Zawsze | W 2 chorobach |
| STUB1STIP1 homology and U-box containing protein 1 | Zawsze | W 1 chorobie |
| ATP7BATPase copper transporting beta | Bardzo często (80–99%) | W 1 chorobie |
| BAZ1Bbromodomain adjacent to zinc finger domain 1B | Bardzo często (80–99%) | W 1 chorobie |
| BUD23BUD23 rRNA methyltransferase and ribosome maturation factor | Bardzo często (80–99%) | W 1 chorobie |
| CASRcalcium sensing receptor | Bardzo często (80–99%) | W 1 chorobie |
| CD4CD4 molecule | Bardzo często (80–99%) | W 1 chorobie |
| CLIP2CAP-Gly domain containing linker protein 2 | Bardzo często (80–99%) | W 1 chorobie |
| DCTN1dynactin subunit 1 | Bardzo często (80–99%) | W 3 chorobach |
| DNAJC30DnaJ heat shock protein family (Hsp40) member C30 | Bardzo często (80–99%) | W 1 chorobie |
| EIF4Heukaryotic translation initiation factor 4H | Bardzo często (80–99%) | W 1 chorobie |
| ELNelastin | Bardzo często (80–99%) | W 1 chorobie |
| FKBP6FKBP prolyl isomerase family member 6 (inactive) | Bardzo często (80–99%) | W 1 chorobie |
| GNA11G protein subunit alpha 11 | Bardzo często (80–99%) | W 1 chorobie |
| GTF2Igeneral transcription factor IIi | Bardzo często (80–99%) | W 1 chorobie |
| GTF2IRD1GTF2I repeat domain containing 1 | Bardzo często (80–99%) | W 1 chorobie |
| GTF2IRD2GTF2I repeat domain containing 2 | Bardzo często (80–99%) | W 1 chorobie |
| IRF4interferon regulatory factor 4 | Bardzo często (80–99%) | W 1 chorobie |
| LIMK1LIM domain kinase 1 | Bardzo często (80–99%) | W 1 chorobie |
| METTL27methyltransferase like 27 | Bardzo często (80–99%) | W 1 chorobie |
| NCF1neutrophil cytosolic factor 1 | Bardzo często (80–99%) | W 1 chorobie |
| OCRLOCRL inositol polyphosphate-5-phosphatase | Bardzo często (80–99%) | W 1 chorobie |
Pokaż jeszcze 424 genów
| Gen | Jak często występuje | Choroby |
|---|---|---|
| PRNPprion protein (Kanno blood group) | Bardzo często (80–99%) | W 7 chorobach |
| RFC2replication factor C subunit 2 | Bardzo często (80–99%) | W 1 chorobie |
| STX1Asyntaxin 1A | Bardzo często (80–99%) | W 2 chorobach |
| TBL2transducin beta like 2 | Bardzo często (80–99%) | W 1 chorobie |
| TMEM270transmembrane protein 270 | Bardzo często (80–99%) | W 1 chorobie |
| VPS37DVPS37D subunit of ESCRT-I | Bardzo często (80–99%) | W 1 chorobie |
| WFS1wolframin ER transmembrane glycoprotein | Bardzo często (80–99%) | W 2 chorobach |
| AARS2alanyl-tRNA synthetase 2, mitochondrial | Często (30–79%) | W 1 chorobie |
| AIPAHR interacting HSP90 co-chaperone | Często (30–79%) | W 1 chorobie |
| ANGangiogenin | Często (30–79%) | W 1 chorobie |
| ANXA11annexin A11 | Często (30–79%) | W 1 chorobie |
| ARL6ARF like GTPase 6 | Często (30–79%) | W 1 chorobie |
| ARMC5armadillo repeat containing 5 | Często (30–79%) | W 2 chorobach |
| ATMATM serine/threonine kinase | Często (30–79%) | W 1 chorobie |
| ATP9AATPase phospholipid transporting 9A | Często (30–79%) | W 1 chorobie |
| ATXN2ataxin 2 | Często (30–79%) | W 2 chorobach |
| BBIP1BBSome interacting protein 1 | Często (30–79%) | W 1 chorobie |
| BBS1Bardet-Biedl syndrome 1 | Często (30–79%) | W 1 chorobie |
| BBS10Bardet-Biedl syndrome 10 | Często (30–79%) | W 1 chorobie |
| BBS12Bardet-Biedl syndrome 12 | Często (30–79%) | W 1 chorobie |
| BBS2Bardet-Biedl syndrome 2 | Często (30–79%) | W 1 chorobie |
| BBS4Bardet-Biedl syndrome 4 | Często (30–79%) | W 1 chorobie |
| BBS5Bardet-Biedl syndrome 5 | Często (30–79%) | W 1 chorobie |
| BBS7Bardet-Biedl syndrome 7 | Często (30–79%) | W 1 chorobie |
| BBS9Bardet-Biedl syndrome 9 | Często (30–79%) | W 1 chorobie |
| BMPR1Abone morphogenetic protein receptor type 1A | Często (30–79%) | W 1 chorobie |
| BRCA2BRCA2 DNA repair associated | Często (30–79%) | W 1 chorobie |
| CACNA1Gcalcium voltage-gated channel subunit alpha1 G | Często (30–79%) | W 2 chorobach |
| CCNFcyclin F | Często (30–79%) | W 1 chorobie |
| CDONcell adhesion associated, oncogene regulated | Często (30–79%) | W 4 chorobach |
| CEP19centrosomal protein 19 | Często (30–79%) | W 1 chorobie |
| CEP290centrosomal protein 290 | Często (30–79%) | W 1 chorobie |
| CFAP410cilia and flagella associated protein 410 | Często (30–79%) | W 1 chorobie |
| CFAP418cilia and flagella associated protein 418 | Często (30–79%) | W 1 chorobie |
| CHCHD10coiled-coil-helix-coiled-coil-helix domain containing 10 | Często (30–79%) | W 2 chorobach |
| CHD7chromodomain helicase DNA binding protein 7 | Często (30–79%) | W 1 chorobie |
| CHEK2checkpoint kinase 2 | Często (30–79%) | W 1 chorobie |
| CHMP2Bcharged multivesicular body protein 2B | Często (30–79%) | W 2 chorobach |
| COL7A1collagen type VII alpha 1 chain | Często (30–79%) | W 2 chorobach |
| COQ2coenzyme Q2, polyprenyltransferase | Często (30–79%) | W 2 chorobach |
| CRIPTOcripto, EGF-CFC family member | Często (30–79%) | W 4 chorobach |
| DAOD-amino acid oxidase | Często (30–79%) | W 1 chorobie |
| DISP1dispatched RND transporter family member 1 | Często (30–79%) | W 4 chorobach |
| DLL1delta like canonical Notch ligand 1 | Często (30–79%) | W 4 chorobach |
| DNA2DNA replication helicase/nuclease 2 | Często (30–79%) | W 2 chorobach |
| DNAJC6DnaJ heat shock protein family (Hsp40) member C6 | Często (30–79%) | W 1 chorobie |
| DNMT1DNA methyltransferase 1 | Często (30–79%) | W 2 chorobach |
| DRD2dopamine receptor D2 | Często (30–79%) | W 1 chorobie |
| DUSP6dual specificity phosphatase 6 | Często (30–79%) | W 1 chorobie |
| EMX2empty spiracles homeobox 2 | Często (30–79%) | W 1 chorobie |
| EPCAMepithelial cell adhesion molecule | Często (30–79%) | W 1 chorobie |
| EPM2AEPM2A glucan phosphatase, laforin | Często (30–79%) | W 1 chorobie |
| ERBB4erb-b2 receptor tyrosine kinase 4 | Często (30–79%) | W 1 chorobie |
| FGF17fibroblast growth factor 17 | Często (30–79%) | W 1 chorobie |
| FGF8fibroblast growth factor 8 | Często (30–79%) | W 5 chorobach |
| FGFR1fibroblast growth factor receptor 1 | Często (30–79%) | W 3 chorobach |
| FIG4FIG4 phosphoinositide 5-phosphatase | Często (30–79%) | W 1 chorobie |
| FLT4fms related receptor tyrosine kinase 4 | Często (30–79%) | W 1 chorobie |
| FMR1fragile X messenger ribonucleoprotein 1 | Często (30–79%) | W 2 chorobach |
| FOXH1forkhead box H1 | Często (30–79%) | W 4 chorobach |
| FUSFUS RNA binding protein | Często (30–79%) | W 2 chorobach |
| GAS1growth arrest specific 1 | Często (30–79%) | W 4 chorobach |
| GCH1GTP cyclohydrolase 1 | Często (30–79%) | W 1 chorobie |
| GDAP2ganglioside induced differentiation associated protein 2 | Często (30–79%) | W 1 chorobie |
| GLE1GLE1 RNA export mediator | Często (30–79%) | W 1 chorobie |
| GLI2GLI family zinc finger 2 | Często (30–79%) | W 4 chorobach |
| GLT8D1glycosyltransferase 8 domain containing 1 | Często (30–79%) | W 1 chorobie |
| GNASGNAS complex locus | Często (30–79%) | W 5 chorobach |
| GNRH1gonadotropin releasing hormone 1 | Często (30–79%) | W 1 chorobie |
| GNRHRgonadotropin releasing hormone receptor | Często (30–79%) | W 1 chorobie |
| GPR101G protein-coupled receptor 101 | Często (30–79%) | W 1 chorobie |
| GPRC5BG protein-coupled receptor class C group 5 member B | Często (30–79%) | W 1 chorobie |
| GRNgranulin precursor | Często (30–79%) | W 1 chorobie |
| GUK1guanylate kinase 1 | Często (30–79%) | W 1 chorobie |
| HLA-Bmajor histocompatibility complex, class I, B | Często (30–79%) | W 1 chorobie |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Często (30–79%) | W 4 chorobach |
| HNRNPA1heterogeneous nuclear ribonucleoprotein A1 | Często (30–79%) | W 1 chorobie |
| HS6ST1heparan sulfate 6-O-sulfotransferase 1 | Często (30–79%) | W 1 chorobie |
| HTRA2HtrA serine peptidase 2 | Często (30–79%) | W 1 chorobie |
| HTThuntingtin | Często (30–79%) | W 3 chorobach |
| IDUAalpha-L-iduronidase | Często (30–79%) | W 1 chorobie |
| IFNGinterferon gamma | Często (30–79%) | W 1 chorobie |
| IFT172intraflagellar transport 172 | Często (30–79%) | W 1 chorobie |
| IFT27intraflagellar transport 27 | Często (30–79%) | W 1 chorobie |
| IFT74intraflagellar transport 74 | Często (30–79%) | W 1 chorobie |
| IMPDH2inosine monophosphate dehydrogenase 2 | Często (30–79%) | W 1 chorobie |
| KCTD17potassium channel tetramerization domain containing 17 | Często (30–79%) | W 2 chorobach |
| KDM1Alysine demethylase 1A | Często (30–79%) | W 1 chorobie |
| KISS1KiSS-1 metastasis suppressor | Często (30–79%) | W 1 chorobie |
| KISS1RKISS1 receptor | Często (30–79%) | W 1 chorobie |
| KRASKRas proto-oncogene, GTPase | Często (30–79%) | W 1 chorobie |
| LRP12LDL receptor related protein 12 | Często (30–79%) | W 1 chorobie |
| LRRK2leucine rich repeat kinase 2 | Często (30–79%) | W 2 chorobach |
| LZTFL1leucine zipper transcription factor like 1 | Często (30–79%) | W 1 chorobie |
| MAPTmicrotubule associated protein tau | Często (30–79%) | W 3 chorobach |
| MATR3matrin 3 | Często (30–79%) | W 1 chorobie |
| MKKSMKKS centrosomal shuttling protein | Często (30–79%) | W 1 chorobie |
| MKS1MKS transition zone complex subunit 1 | Często (30–79%) | W 1 chorobie |
| MLH1mutL homolog 1 | Często (30–79%) | W 1 chorobie |
| MMP1matrix metallopeptidase 1 | Często (30–79%) | W 1 chorobie |
| MSH2mutS homolog 2 | Często (30–79%) | W 1 chorobie |
| MSH6mutS homolog 6 | Często (30–79%) | W 1 chorobie |
| MSTO1misato mitochondrial distribution and morphology regulator 1 | Często (30–79%) | W 2 chorobach |
| MT-CO1mitochondrially encoded cytochrome c oxidase I | Często (30–79%) | W 1 chorobie |
| MT-CO2mitochondrially encoded cytochrome c oxidase II | Często (30–79%) | W 1 chorobie |
| MT-CO3mitochondrially encoded cytochrome c oxidase III | Często (30–79%) | W 1 chorobie |
| MT-ND1mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 | Często (30–79%) | W 1 chorobie |
| MT-ND4mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 | Często (30–79%) | W 1 chorobie |
| MT-ND5mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5 | Często (30–79%) | W 1 chorobie |
| MT-ND6mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 | Często (30–79%) | W 1 chorobie |
| MT-TFmitochondrially encoded tRNA-Phe (UUU/C) | Często (30–79%) | W 1 chorobie |
| MT-THmitochondrially encoded tRNA-His (CAU/C) | Często (30–79%) | W 1 chorobie |
| MT-TL1mitochondrially encoded tRNA-Leu (UUA/G) 1 | Często (30–79%) | W 2 chorobach |
| MT-TQmitochondrially encoded tRNA-Gln (CAA/G) | Często (30–79%) | W 1 chorobie |
| MT-TS1mitochondrially encoded tRNA-Ser (UCN) 1 | Często (30–79%) | W 2 chorobach |
| MT-TS2mitochondrially encoded tRNA-Ser (AGU/C) 2 | Często (30–79%) | W 2 chorobach |
| MT-TWmitochondrially encoded tRNA-Trp (UGA/G) | Często (30–79%) | W 1 chorobie |
| MUTYHmutY DNA glycosylase | Często (30–79%) | W 1 chorobie |
| NEFHneurofilament heavy chain | Często (30–79%) | W 1 chorobie |
| NEK1NIMA related kinase 1 | Często (30–79%) | W 1 chorobie |
| NHLH2nescient helix-loop-helix 2 | Często (30–79%) | W 1 chorobie |
| NHLRC1NHL repeat containing E3 ubiquitin protein ligase 1 | Często (30–79%) | W 1 chorobie |
| NODALnodal growth differentiation factor | Często (30–79%) | W 4 chorobach |
| NPATnuclear protein, coactivator of histone transcription | Często (30–79%) | W 1 chorobie |
| NPHP1nephrocystin 1 | Często (30–79%) | W 1 chorobie |
| NR4A2nuclear receptor subfamily 4 group A member 2 | Często (30–79%) | W 2 chorobach |
| NSMFNMDA receptor synaptonuclear signaling and neuronal migration factor | Często (30–79%) | W 1 chorobie |
| OPTNoptineurin | Często (30–79%) | W 1 chorobie |
| P4HA2prolyl 4-hydroxylase subunit alpha 2 | Często (30–79%) | W 1 chorobie |
| PANK2pantothenate kinase 2 | Często (30–79%) | W 2 chorobach |
| PARK7Parkinsonism associated deglycase | Często (30–79%) | W 1 chorobie |
| PDGFRBplatelet derived growth factor receptor beta | Często (30–79%) | W 3 chorobach |
| PFN1profilin 1 | Często (30–79%) | W 1 chorobie |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Często (30–79%) | W 1 chorobie |
| PINK1PTEN induced kinase 1 | Często (30–79%) | W 2 chorobach |
| PLA2G6phospholipase A2 group VI | Często (30–79%) | W 2 chorobach |
| PLCH1phospholipase C eta 1 | Często (30–79%) | W 1 chorobie |
| PMS1PMS1 homolog 1, mismatch repair system component | Często (30–79%) | W 1 chorobie |
| PMS2PMS1 homolog 2, mismatch repair system component | Często (30–79%) | W 1 chorobie |
| PODXLpodocalyxin like | Często (30–79%) | W 1 chorobie |
| POLD1DNA polymerase delta 1, catalytic subunit | Często (30–79%) | W 1 chorobie |
| POLEDNA polymerase epsilon, catalytic subunit | Często (30–79%) | W 1 chorobie |
| POLGDNA polymerase gamma, catalytic subunit | Często (30–79%) | W 7 chorobach |
| PRKNparkin RBR E3 ubiquitin protein ligase | Często (30–79%) | W 1 chorobie |
| PROK2prokineticin 2 | Często (30–79%) | W 1 chorobie |
| PROKR2prokineticin receptor 2 | Często (30–79%) | W 1 chorobie |
| PRPHperipherin | Często (30–79%) | W 1 chorobie |
| PSAPprosaposin | Często (30–79%) | W 2 chorobach |
| PSEN1presenilin 1 | Często (30–79%) | W 1 chorobie |
| PTCH1patched 1 | Często (30–79%) | W 4 chorobach |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Często (30–79%) | W 2 chorobach |
| RAB32RAB32, member RAS oncogene family | Często (30–79%) | W 1 chorobie |
| RPS20ribosomal protein S20 | Często (30–79%) | W 1 chorobie |
| SCAPERS-phase cyclin A associated protein in the ER | Często (30–79%) | W 1 chorobie |
| SCLT1sodium channel and clathrin linker 1 | Często (30–79%) | W 1 chorobie |
| SDCCAG8SHH signaling and ciliogenesis regulator SDCCAG8 | Często (30–79%) | W 1 chorobie |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Często (30–79%) | W 1 chorobie |
| SEMA4Asemaphorin 4A | Często (30–79%) | W 1 chorobie |
| SHHsonic hedgehog signaling molecule | Często (30–79%) | W 4 chorobach |
| SIX3SIX homeobox 3 | Często (30–79%) | W 4 chorobach |
| SLC2A3solute carrier family 2 member 3 | Często (30–79%) | W 1 chorobie |
| SLC7A6OSsolute carrier family 7 member 6 opposite strand | Często (30–79%) | W 1 chorobie |
| SMC1Astructural maintenance of chromosomes 1A | Często (30–79%) | W 1 chorobie |
| SNCAsynuclein alpha | Często (30–79%) | W 3 chorobach |
| SOD1superoxide dismutase 1 | Często (30–79%) | W 1 chorobie |
| SPRsepiapterin reductase | Często (30–79%) | W 1 chorobie |
| SPRY4sprouty RTK signaling antagonist 4 | Często (30–79%) | W 1 chorobie |
| SQSTM1sequestosome 1 | Często (30–79%) | W 2 chorobach |
| STAG2STAG2 cohesin complex component | Często (30–79%) | W 2 chorobach |
| STILSTIL centriolar assembly protein | Często (30–79%) | W 4 chorobach |
| SYNJ1synaptojanin 1 | Często (30–79%) | W 1 chorobie |
| TAC3tachykinin precursor 3 | Często (30–79%) | W 1 chorobie |
| TACR3tachykinin receptor 3 | Często (30–79%) | W 1 chorobie |
| TAF15TATA-box binding protein associated factor 15 | Często (30–79%) | W 1 chorobie |
| TARDBPTAR DNA binding protein | Często (30–79%) | W 2 chorobach |
| TBK1TANK binding kinase 1 | Często (30–79%) | W 2 chorobach |
| TGFBR2transforming growth factor beta receptor 2 | Często (30–79%) | W 1 chorobie |
| TGIF1TGFB induced factor homeobox 1 | Często (30–79%) | W 4 chorobach |
| TMEM106Btransmembrane protein 106B | Często (30–79%) | W 1 chorobie |
| TOR1Atorsin family 1 member A | Często (30–79%) | W 2 chorobach |
| TPH2tryptophan hydroxylase 2 | Często (30–79%) | W 2 chorobach |
| TRANK1tetratricopeptide repeat and ankyrin repeat containing 1 | Często (30–79%) | W 1 chorobie |
| TREM2triggering receptor expressed on myeloid cells 2 | Często (30–79%) | W 2 chorobach |
| TRHRthyrotropin releasing hormone receptor | Często (30–79%) | W 1 chorobie |
| TRIM32tripartite motif containing 32 | Często (30–79%) | W 1 chorobie |
| TSC1TSC complex subunit 1 | Często (30–79%) | W 1 chorobie |
| TSC2TSC complex subunit 2 | Często (30–79%) | W 1 chorobie |
| TTC8tetratricopeptide repeat domain 8 | Często (30–79%) | W 1 chorobie |
| UBQLN2ubiquilin 2 | Często (30–79%) | W 1 chorobie |
| UCHL1ubiquitin C-terminal hydrolase L1 | Często (30–79%) | W 1 chorobie |
| UNC13Aunc-13 homolog A | Często (30–79%) | W 1 chorobie |
| UQCRC1ubiquinol-cytochrome c reductase core protein 1 | Często (30–79%) | W 1 chorobie |
| VAPBVAMP associated protein B and C | Często (30–79%) | W 1 chorobie |
| VCPvalosin containing protein | Często (30–79%) | W 5 chorobach |
| VPS13Avacuolar protein sorting 13 homolog A | Często (30–79%) | W 2 chorobach |
| VPS13Cvacuolar protein sorting 13 homolog C | Często (30–79%) | W 2 chorobach |
| WARS2tryptophanyl tRNA synthetase 2, mitochondrial | Często (30–79%) | W 1 chorobie |
| WDPCPWD repeat containing planar cell polarity effector | Często (30–79%) | W 1 chorobie |
| WDR11WD repeat domain 11 | Często (30–79%) | W 1 chorobie |
| ZIC2Zic family zinc finger 2 | Często (30–79%) | W 4 chorobach |
| ABCB11ATP binding cassette subfamily B member 11 | Czasami (5–29%) | W 1 chorobie |
| ABCB4ATP binding cassette subfamily B member 4 | Czasami (5–29%) | W 1 chorobie |
| ADA2adenosine deaminase 2 | Czasami (5–29%) | W 1 chorobie |
| ADGRV1adhesion G protein-coupled receptor V1 | Czasami (5–29%) | W 1 chorobie |
| ALADaminolevulinate dehydratase | Czasami (5–29%) | W 1 chorobie |
| ALDH4A1aldehyde dehydrogenase 4 family member A1 | Czasami (5–29%) | W 1 chorobie |
| AOPEPaminopeptidase O (putative) | Czasami (5–29%) | W 1 chorobie |
| AP1G1adaptor related protein complex 1 subunit gamma 1 | Czasami (5–29%) | W 1 chorobie |
| AP2S1adaptor related protein complex 2 subunit sigma 1 | Czasami (5–29%) | W 1 chorobie |
| ARandrogen receptor | Czasami (5–29%) | W 2 chorobach |
| ARSAarylsulfatase A | Czasami (5–29%) | W 1 chorobie |
| ARSGarylsulfatase G | Czasami (5–29%) | W 1 chorobie |
| ARVCFARVCF delta catenin family member | Czasami (5–29%) | W 1 chorobie |
| ATP1A3ATPase Na+/K+ transporting subunit alpha 3 | Czasami (5–29%) | W 2 chorobach |
| ATP2A2ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 | Czasami (5–29%) | W 1 chorobie |
| ATP8B1ATPase phospholipid transporting 8B1 | Czasami (5–29%) | W 1 chorobie |
| ATRXATRX chromatin remodeler | Czasami (5–29%) | W 2 chorobach |
| ATXN10ataxin 10 | Czasami (5–29%) | W 2 chorobach |
| ATXN8ataxin 8 | Czasami (5–29%) | W 1 chorobie |
| ATXN8OSATXN8 opposite strand lncRNA | Czasami (5–29%) | W 2 chorobach |
| BANK1B cell scaffold protein with ankyrin repeats 1 | Czasami (5–29%) | W 1 chorobie |
| BCRBCR activator of RhoGEF and GTPase | Czasami (5–29%) | W 1 chorobie |
| BLKBLK proto-oncogene, Src family tyrosine kinase | Czasami (5–29%) | W 1 chorobie |
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Czasami (5–29%) | W 1 chorobie |
| C1Rcomplement C1r | Czasami (5–29%) | W 1 chorobie |
| C1Scomplement C1s | Czasami (5–29%) | W 1 chorobie |
| C4Acomplement C4A (Chido/Rodgers blood group) | Czasami (5–29%) | W 1 chorobie |
| C4Bcomplement C4B (Chido/Rodgers blood group) | Czasami (5–29%) | W 1 chorobie |
| CABP4calcium binding protein 4 | Czasami (5–29%) | W 1 chorobie |
| CACNA1Hcalcium voltage-gated channel subunit alpha1 H | Czasami (5–29%) | W 1 chorobie |
| CACNA1Icalcium voltage-gated channel subunit alpha1 I | Czasami (5–29%) | W 1 chorobie |
| CARS1cysteinyl-tRNA synthetase 1 | Czasami (5–29%) | W 1 chorobie |
| CBScystathionine beta-synthase | Czasami (5–29%) | W 2 chorobach |
| CDH23cadherin related 23 | Czasami (5–29%) | W 2 chorobach |
| CDKN1Bcyclin dependent kinase inhibitor 1B | Czasami (5–29%) | W 1 chorobie |
| CDKN2Bcyclin dependent kinase inhibitor 2B | Czasami (5–29%) | W 1 chorobie |
| CEACAM3CEA cell adhesion molecule 3 | Czasami (5–29%) | W 1 chorobie |
| CEACAM6CEA cell adhesion molecule 6 | Czasami (5–29%) | W 1 chorobie |
| CEP78centrosomal protein 78 | Czasami (5–29%) | W 1 chorobie |
| CEP85Lcentrosomal protein 85L | Czasami (5–29%) | W 1 chorobie |
| CFTRCF transmembrane conductance regulator | Czasami (5–29%) | W 1 chorobie |
| CHCHD2coiled-coil-helix-coiled-coil-helix domain containing 2 | Czasami (5–29%) | W 1 chorobie |
| CHD8chromodomain helicase DNA binding protein 8 | Czasami (5–29%) | W 1 chorobie |
| CHRNA2cholinergic receptor nicotinic alpha 2 subunit | Czasami (5–29%) | W 1 chorobie |
| CHRNA4cholinergic receptor nicotinic alpha 4 subunit | Czasami (5–29%) | W 1 chorobie |
| CHRNB2cholinergic receptor nicotinic beta 2 subunit | Czasami (5–29%) | W 1 chorobie |
| CLCA4chloride channel accessory 4 | Czasami (5–29%) | W 1 chorobie |
| CLCN4Cl-/H+ antiporter 4 | Czasami (5–29%) | W 2 chorobach |
| CLRN1clarin 1 | Czasami (5–29%) | W 1 chorobie |
| COMTcatechol-O-methyltransferase | Czasami (5–29%) | W 1 chorobie |
| CR2complement C3d receptor 2 | Czasami (5–29%) | W 1 chorobie |
| CRHcorticotropin releasing hormone | Czasami (5–29%) | W 1 chorobie |
| CRKLCRK like proto-oncogene, adaptor protein | Czasami (5–29%) | W 1 chorobie |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Czasami (5–29%) | W 1 chorobie |
| CTSFcathepsin F | Czasami (5–29%) | W 1 chorobie |
| CTSHcathepsin H | Czasami (5–29%) | W 1 chorobie |
| CYP27A1cytochrome P450 family 27 subfamily A member 1 | Czasami (5–29%) | W 1 chorobie |
| DCTN4dynactin subunit 4 | Czasami (5–29%) | W 1 chorobie |
| DEPDC5DEP domain containing 5, GATOR1 subcomplex subunit | Czasami (5–29%) | W 1 chorobie |
| DGUOKdeoxyguanosine kinase | Czasami (5–29%) | W 1 chorobie |
| DNAJC13DnaJ heat shock protein family (Hsp40) member C13 | Czasami (5–29%) | W 1 chorobie |
| DNASE1deoxyribonuclease 1 | Czasami (5–29%) | W 1 chorobie |
| EDNRAendothelin receptor type A | Czasami (5–29%) | W 1 chorobie |
| EHMT1euchromatic histone lysine methyltransferase 1 | Czasami (5–29%) | W 2 chorobach |
| EIF4G1eukaryotic translation initiation factor 4 gamma 1 | Czasami (5–29%) | W 1 chorobie |
| ESPNespin | Czasami (5–29%) | W 1 chorobie |
| ETS1ETS proto-oncogene 1, transcription factor | Czasami (5–29%) | W 1 chorobie |
| FCGR2BFc gamma receptor IIb | Czasami (5–29%) | W 1 chorobie |
| FCGR3BFc gamma receptor IIIb | Czasami (5–29%) | W 1 chorobie |
| FGF14fibroblast growth factor 14 | Czasami (5–29%) | W 2 chorobach |
| FMO3flavin containing dimethylaniline monoxygenase 3 | Czasami (5–29%) | W 2 chorobach |
| FXNfrataxin | Czasami (5–29%) | W 1 chorobie |
| GABRA1gamma-aminobutyric acid type A receptor subunit alpha1 | Czasami (5–29%) | W 1 chorobie |
| GABRB3gamma-aminobutyric acid type A receptor subunit beta3 | Czasami (5–29%) | W 1 chorobie |
| GABRG2gamma-aminobutyric acid type A receptor subunit gamma2 | Czasami (5–29%) | W 2 chorobach |
| GALTgalactose-1-phosphate uridylyltransferase | Czasami (5–29%) | W 1 chorobie |
| GBA1glucosylceramidase beta 1 | Czasami (5–29%) | W 4 chorobach |
| GCLCglutamate-cysteine ligase catalytic subunit | Czasami (5–29%) | W 1 chorobie |
| GIGYF2GRB10 interacting GYF protein 2 | Czasami (5–29%) | W 1 chorobie |
| GLAgalactosidase alpha | Czasami (5–29%) | W 1 chorobie |
| GP1BBglycoprotein Ib platelet subunit beta | Czasami (5–29%) | W 1 chorobie |
| GPR35G protein-coupled receptor 35 | Czasami (5–29%) | W 1 chorobie |
| GRIN2Aglutamate ionotropic receptor NMDA type subunit 2A | Czasami (5–29%) | W 2 chorobach |
| GSTM3glutathione S-transferase mu 3 | Czasami (5–29%) | W 1 chorobie |
| HARS1histidyl-tRNA synthetase 1 | Czasami (5–29%) | W 1 chorobie |
| HCRThypocretin neuropeptide precursor | Czasami (5–29%) | W 1 chorobie |
| HFEhomeostatic iron regulator | Czasami (5–29%) | W 1 chorobie |
| HIRAhistone cell cycle regulator | Czasami (5–29%) | W 1 chorobie |
| HLA-DQB1major histocompatibility complex, class II, DQ beta 1 | Czasami (5–29%) | W 4 chorobach |
| HMBShydroxymethylbilane synthase | Czasami (5–29%) | W 2 chorobach |
| HMOX1heme oxygenase 1 | Czasami (5–29%) | W 1 chorobie |
| IGHG1immunoglobulin heavy constant gamma 1 (G1m marker) | Czasami (5–29%) | W 1 chorobie |
| IL10interleukin 10 | Czasami (5–29%) | W 1 chorobie |
| IRAK1interleukin 1 receptor associated kinase 1 | Czasami (5–29%) | W 1 chorobie |
| IRF5interferon regulatory factor 5 | Czasami (5–29%) | W 1 chorobie |
| ITGAMintegrin subunit alpha M | Czasami (5–29%) | W 1 chorobie |
| JAZF1JAZF zinc finger 1 | Czasami (5–29%) | W 1 chorobie |
| JMJD1Cjumonji domain containing 1C | Czasami (5–29%) | W 1 chorobie |
| JRKJrk helix-turn-helix protein | Czasami (5–29%) | W 1 chorobie |
| KCNN4potassium calcium-activated channel subfamily N member 4 | Czasami (5–29%) | W 1 chorobie |
| KCNT1potassium sodium-activated channel subfamily T member 1 | Czasami (5–29%) | W 2 chorobach |
| KIAA0319LKIAA0319 like | Czasami (5–29%) | W 1 chorobie |
| KMT2Blysine methyltransferase 2B | Czasami (5–29%) | W 1 chorobie |
| LAMP2lysosome associated membrane protein 2 | Czasami (5–29%) | W 1 chorobie |
| MAMLD1mastermind like domain containing 1 | Czasami (5–29%) | W 1 chorobie |
| MAN2B1mannosidase alpha class 2B member 1 | Czasami (5–29%) | W 2 chorobach |
| MAPK1mitogen-activated protein kinase 1 | Czasami (5–29%) | W 1 chorobie |
| MECP2methyl-CpG binding protein 2 | Czasami (5–29%) | W 2 chorobach |
| MEFVMEFV innate immunity regulator, pyrin | Czasami (5–29%) | W 1 chorobie |
| MEN1menin 1 | Czasami (5–29%) | W 1 chorobie |
| MIFmacrophage migration inhibitory factor | Czasami (5–29%) | W 1 chorobie |
| MOGmyelin oligodendrocyte glycoprotein | Czasami (5–29%) | W 1 chorobie |
| MST1macrophage stimulating 1 | Czasami (5–29%) | W 1 chorobie |
| MT-TL2mitochondrially encoded tRNA-Leu (CUN) 2 | Czasami (5–29%) | W 1 chorobie |
| MT-TNmitochondrially encoded tRNA-Asn (AAU/C) | Czasami (5–29%) | W 1 chorobie |
| MYO7Amyosin VIIA | Czasami (5–29%) | W 2 chorobach |
| NAA60N-alpha-acetyltransferase 60, NatF catalytic subunit | Czasami (5–29%) | W 2 chorobach |
| NIT1nitrilase 1 | Czasami (5–29%) | W 1 chorobie |
| NOTCH3notch receptor 3 | Czasami (5–29%) | W 1 chorobie |
| NR1H4nuclear receptor subfamily 1 group H member 4 | Czasami (5–29%) | W 1 chorobie |
| NR3C1nuclear receptor subfamily 3 group C member 1 | Czasami (5–29%) | W 1 chorobie |
| OTCornithine transcarbamylase | Czasami (5–29%) | W 1 chorobie |
| P2RY11purinergic receptor P2Y11 | Czasami (5–29%) | W 1 chorobie |
| PCDH15protocadherin related 15 | Czasami (5–29%) | W 1 chorobie |
| PDCD1programmed cell death 1 | Czasami (5–29%) | W 1 chorobie |
| PDGFBplatelet derived growth factor subunit B | Czasami (5–29%) | W 2 chorobach |
| PDZD7PDZ domain containing 7 | Czasami (5–29%) | W 1 chorobie |
| PTPAprotein phosphatase 2 phosphatase activator | Czasami (5–29%) | W 1 chorobie |
| PTRHD1peptidyl-tRNA hydrolase domain containing 1 | Czasami (5–29%) | W 1 chorobie |
| PTS6-pyruvoyltetrahydropterin synthase | Czasami (5–29%) | W 1 chorobie |
| PXKPX domain containing serine/threonine kinase like | Czasami (5–29%) | W 1 chorobie |
| RPS6KA3ribosomal protein S6 kinase A3 | Czasami (5–29%) | W 1 chorobie |
| RPS6KC1ribosomal protein S6 kinase C1 | Czasami (5–29%) | W 1 chorobie |
| RREB1ras responsive element binding protein 1 | Czasami (5–29%) | W 1 chorobie |
| RRM1ribonucleotide reductase catalytic subunit M1 | Czasami (5–29%) | W 1 chorobie |
| RRM2Bribonucleotide reductase regulatory TP53 inducible subunit M2B | Czasami (5–29%) | W 2 chorobach |
| SCARB2scavenger receptor class B member 2 | Czasami (5–29%) | W 1 chorobie |
| SEC24CSEC24 homolog C, COPII component | Czasami (5–29%) | W 1 chorobie |
| SEMA4Dsemaphorin 4D | Czasami (5–29%) | W 1 chorobie |
| SERPINA1serpin family A member 1 | Czasami (5–29%) | W 1 chorobie |
| SLC11A1solute carrier family 11 member 1 | Czasami (5–29%) | W 1 chorobie |
| SLC25A4solute carrier family 25 member 4 | Czasami (5–29%) | W 1 chorobie |
| SLC26A9solute carrier family 26 member 9 | Czasami (5–29%) | W 1 chorobie |
| SLC6A14solute carrier family 6 member 14 | Czasami (5–29%) | W 1 chorobie |
| SLC9A3solute carrier family 9 member A3 | Czasami (5–29%) | W 1 chorobie |
| SPP1secreted phosphoprotein 1 | Czasami (5–29%) | W 1 chorobie |
| SPTBN1spectrin beta, non-erythrocytic 1 | Czasami (5–29%) | W 1 chorobie |
| SRPX2sushi repeat containing protein X-linked 2 | Czasami (5–29%) | W 1 chorobie |
| STAT4signal transducer and activator of transcription 4 | Czasami (5–29%) | W 1 chorobie |
| STX16syntaxin 16 | Czasami (5–29%) | W 1 chorobie |
| TAFAZZINtafazzin, phospholipid-lysophospholipid transacylase | Czasami (5–29%) | W 1 chorobie |
| TBX1T-box transcription factor 1 | Czasami (5–29%) | W 1 chorobie |
| TCF4transcription factor 4 | Czasami (5–29%) | W 1 chorobie |
| TET3tet methylcytosine dioxygenase 3 | Czasami (5–29%) | W 1 chorobie |
| TGFB1transforming growth factor beta 1 | Czasami (5–29%) | W 1 chorobie |
| THOC2THO complex subunit 2 | Czasami (5–29%) | W 2 chorobach |
| TK2thymidine kinase 2 | Czasami (5–29%) | W 1 chorobie |
| TLR7toll like receptor 7 | Czasami (5–29%) | W 1 chorobie |
| TNFAIP3TNF alpha induced protein 3 | Czasami (5–29%) | W 1 chorobie |
| TNFSF4TNF superfamily member 4 | Czasami (5–29%) | W 2 chorobach |
| TNIP1TNFAIP3 interacting protein 1 | Czasami (5–29%) | W 1 chorobie |
| TOP3ADNA topoisomerase III alpha | Czasami (5–29%) | W 1 chorobie |
| TP53tumor protein p53 | Czasami (5–29%) | W 1 chorobie |
| TREX1three prime repair exonuclease 1 | Czasami (5–29%) | W 2 chorobach |
| TWNKtwinkle mtDNA helicase | Czasami (5–29%) | W 4 chorobach |
| UBE2L3ubiquitin conjugating enzyme E2 L3 | Czasami (5–29%) | W 1 chorobie |
| UFD1ubiquitin recognition factor in ER associated degradation 1 | Czasami (5–29%) | W 1 chorobie |
| USH1CUSH1 protein network component harmonin | Czasami (5–29%) | W 1 chorobie |
| USH1GUSH1 protein network component sans | Czasami (5–29%) | W 1 chorobie |
| USH2Ausherin | Czasami (5–29%) | W 1 chorobie |
| USP48ubiquitin specific peptidase 48 | Czasami (5–29%) | W 1 chorobie |
| USP8ubiquitin specific peptidase 8 | Czasami (5–29%) | W 1 chorobie |
| VPS35VPS35 retromer complex component | Czasami (5–29%) | W 1 chorobie |
| WHRNwhirlin | Czasami (5–29%) | W 1 chorobie |
| ZFXzinc finger protein X-linked | Czasami (5–29%) | W 1 chorobie |
| ZNF365zinc finger protein 365 | Czasami (5–29%) | W 1 chorobie |
| AFG3L2AFG3 like matrix AAA peptidase subunit 2 | Rzadko (1–4%) | W 2 chorobach |
| ATP13A2ATPase cation transporting 13A2 | Rzadko (1–4%) | W 1 chorobie |
| CTCFCCCTC-binding factor | Rzadko (1–4%) | W 1 chorobie |
| FA2Hfatty acid 2-hydroxylase | Rzadko (1–4%) | W 1 chorobie |
| GSNgelsolin | Rzadko (1–4%) | W 1 chorobie |
| KDM6Blysine demethylase 6B | Rzadko (1–4%) | W 1 chorobie |
| LGI1leucine rich glioma inactivated 1 | Rzadko (1–4%) | W 1 chorobie |
| MICAL1microtubule associated monooxygenase, calponin and LIM domain containing 1 | Rzadko (1–4%) | W 1 chorobie |
| RELNreelin | Rzadko (1–4%) | W 1 chorobie |
| SMPD1sphingomyelin phosphodiesterase 1 | Rzadko (1–4%) | W 1 chorobie |
| TSHBthyroid stimulating hormone subunit beta | Rzadko (1–4%) | W 1 chorobie |
| ABCA7ATP binding cassette subfamily A member 7 | Nie odnotowano | W 1 chorobie |
| ADH1Calcohol dehydrogenase 1C (class I), gamma polypeptide | Nie odnotowano | W 1 chorobie |
| ATXN3ataxin 3 | Nie odnotowano | W 1 chorobie |
| BCS1LBCS1 ubiquinol-cytochrome c reductase complex chaperone | Nie odnotowano | W 1 chorobie |
| C19orf12chromosome 19 open reading frame 12 | Nie odnotowano | W 1 chorobie |
| C9orf72C9orf72-SMCR8 complex subunit | Nie odnotowano | W 1 chorobie |
| CISD2CDGSH iron sulfur domain 2 | Nie odnotowano | W 1 chorobie |
| CLN6CLN6 transmembrane ER protein | Nie odnotowano | W 1 chorobie |
| COASYCoenzyme A synthase | Nie odnotowano | W 1 chorobie |
| CPOXcoproporphyrinogen oxidase | Nie odnotowano | W 1 chorobie |
| CSF1Rcolony stimulating factor 1 receptor | Nie odnotowano | W 1 chorobie |
| FKBP5FKBP prolyl isomerase 5 | Nie odnotowano | W 1 chorobie |
| HLA-DQA1major histocompatibility complex, class II, DQ alpha 1 | Nie odnotowano | W 1 chorobie |
| HTR2A5-hydroxytryptamine receptor 2A | Nie odnotowano | W 2 chorobach |
| JAM2junctional adhesion molecule 2 | Nie odnotowano | W 1 chorobie |
| JPH3junctophilin 3 | Nie odnotowano | W 1 chorobie |
| KCNJ2potassium inwardly rectifying channel subfamily J member 2 | Nie odnotowano | W 1 chorobie |
| MT-TTmitochondrially encoded tRNA-Thr (ACN) | Nie odnotowano | W 1 chorobie |
| MYORGmyogenesis regulating glycosidase | Nie odnotowano | W 1 chorobie |
| PAHphenylalanine hydroxylase | Nie odnotowano | W 1 chorobie |
| PDE11Aphosphodiesterase 11A | Nie odnotowano | W 1 chorobie |
| PER2period circadian regulator 2 | Nie odnotowano | W 1 chorobie |
| PPP2R2Bprotein phosphatase 2 regulatory subunit Bbeta | Nie odnotowano | W 1 chorobie |
| PPT1palmitoyl-protein thioesterase 1 | Nie odnotowano | W 1 chorobie |
| PRKACAprotein kinase cAMP-activated catalytic subunit alpha | Nie odnotowano | W 1 chorobie |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Nie odnotowano | W 1 chorobie |
| PRKCGprotein kinase C gamma | Nie odnotowano | W 1 chorobie |
| SLC20A2solute carrier family 20 member 2 | Nie odnotowano | W 1 chorobie |
| SLC6A4solute carrier family 6 member 4 | Nie odnotowano | W 1 chorobie |
| SNCAIPsynuclein alpha interacting protein | Nie odnotowano | W 1 chorobie |
| SPASTspastin | Nie odnotowano | W 1 chorobie |
| TBC1D7TBC1 domain family member 7 | Nie odnotowano | W 1 chorobie |
| TBPTATA-box binding protein | Nie odnotowano | W 2 chorobach |
| TDO2tryptophan 2,3-dioxygenase | Nie odnotowano | W 1 chorobie |
| TTC19tetratricopeptide repeat domain 19 | Nie odnotowano | W 1 chorobie |
| XKX-linked Kx blood group antigen, Kell and VPS13A binding protein | Nie odnotowano | W 1 chorobie |
| XPR1xenotropic and polytropic retrovirus receptor 1 | Nie odnotowano | W 2 chorobach |
Jak często występuje wśród osób z jedną z chorób związanych z tym genem, najczęściej spośród wszystkich, według danych Human Phenotype Ontology. Te strony opisują cechy i badania, na których się opierają; nie są diagnozą, a w sprawie objawów należy zwrócić się do lekarza lub doradcy genetycznego.
Cechy nadrzędne
Skąd pochodzą te dane
- Human Phenotype Ontology, wydanie 2026-09-01: cecha, jej nazwy, definicja oraz geny z nią powiązane. Więcej informacji znajdą Państwo na stronie hpo.jax.org.
- Wydanie danych 2026.10.16-c6eea6bf.
Jeden test. Odpowiedzi na całe życie.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni